Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.12M Buy
650,070
+117,742
+22% +$642K ﹤0.01% 3148
2026
Q1
$4.71M Sell
532,328
-73,665
-12% -$768K ﹤0.01% 2229
2025
Q4
$7.2M Buy
605,993
+41,750
+7% +$551K ﹤0.01% 2031
2025
Q3
$7.96M Sell
564,243
-54,580
-9% -$690K ﹤0.01% 1847
2025
Q2
$6M Sell
618,823
-212,744
-26% -$2.39M ﹤0.01% 1888
2025
Q1
$10.6M Sell
831,567
-57,330
-6% -$918K 0.01% 1343
2024
Q4
$18.4M Sell
888,897
-139,903
-14% -$2.29M 0.01% 1083
2024
Q3
$14.5M Sell
1,028,800
-14,043
-1% -$204K 0.01% 1190
2024
Q2
$13M Buy
1,042,843
+202,363
+24% +$2.46M 0.01% 1167
2024
Q1
$11.2M Buy
840,480
+95,601
+13% +$1.48M 0.01% 1288
2023
Q4
$14.1M Buy
744,879
+208,374
+39% +$3.42M 0.01% 1145
2023
Q3
$8.07M Sell
536,505
-42,138
-7% -$790K 0.01% 1434
2023
Q2
$12.5M Buy
578,643
+93,788
+19% +$2.56M 0.01% 1164
2023
Q1
$13.6M Buy
484,855
+113,030
+30% +$3.21M 0.01% 1143
2022
Q4
$9.4M Buy
371,825
+109,613
+42% +$3.35M 0.01% 1494
2022
Q3
$7.55M Buy
262,212
+18,775
+8% +$556K 0.01% 1626
2022
Q2
$6.16M Buy
+243,437
New +$7.02M 0.01% 1881

Other funds holding EMBC

David Shaw's EMBC Position: Q2 2026 in Review

David Shaw increased its Embecta (EMBC) stake by 22% in Q2 2026, buying an estimated $642K and bringing the position to 650,070 shares worth $2.12M. The position accounts for ﹤0.01% of the portfolio, ranked #3148.

David Shaw first reported a position in EMBC in Q2 2022 and has held it in 17 quarters since. The position peaked at $18.4M in Q4 2024. 319 funds tracked by Wall St. Rank hold EMBC as of Q2 2026.

  • David Shaw held 650,070 shares of Embecta worth $2.12M as of Q2 2026.
  • David Shaw bought 117,742 Embecta shares in Q2 2026, an estimated $642K.
  • Embecta made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3148 holding.
  • David Shaw first reported a position in Embecta in Q2 2022 and has held it in 17 quarters since.
  • David Shaw's Embecta position peaked at $18.4M in Q4 2024.
  • 319 funds tracked by Wall St. Rank held Embecta as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.